Surgery Partners: TD Cowen cuts to hold from buy; raises target price to $23.50 from $19
SGRY•TD Cowen cut its rating on Surgery Partners to hold from buy and raised its target price to $23.50 from $19.
Related News
First Solar: Barclays cuts target price to $230 from $259
FSLR•
Tenet Healthcare target price raised to $302 from $263
THC•
Paysafe appoints Rob Schonfeld as chief revenue officer
PSFE•
Fortuna Mining intersects 1.9 g/t gold over 64 meters at Senegal’s Kabewest prospect
FSM•
UK October manufacturing PMI shows fastest output growth in two years
EWU•